Advances in Technology
Process to turn skin cells into motor neurons detailed in 2 papers Scientists have developed a novel method to efficiently grow motor neurons from skin cells, which may serve as…
JERSEY CITY, N.J. March 12, 2025 – Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025…
The U.S. Food and Drug Administration has announced the establishment of a Rare Disease Innovation Hub. The Hub will connect and engage the rare disease community; help the community navigate…
The Golden West Chapter celebrates the Food and Drug Administration’s (FDA) announcement of approval of RELYVRIO (formerly AMX0035) as a new treatment for adults living with amyotrophic lateral sclerosis (ALS),…
Today, we filed comments with the FDA imploring them to ask the right question when it reconvenes its advisory committee in September to consider a new drug application (NDA) for…